(A, B) ET4;ET20 larvae were treated with neomycin, LY411575 (3dpf-5dpf), or neomycin following LY (LY+neo), and collected at indicated time points post neomycin treatment for sox2 immunostaining. …
ET4;ET20 larvae were treated with 2 μM LY from 3dpf to 5dpf followed by neomycin, and the number of HCs, SCs and MCs were counted before and right after neo treatment. Results showed that HCs were …
Larvae treated with neo or LY+neo were incorporated with EdU for different time points and counted for numbers of differentiating cells (EdU+ET4+ cells, HC+), proliferative SCs (EdU+ET4-ET20- cells, …
(A) Lin28a was not expressed in the developing lateral line primordium or neuromast. (B) Treatment with Notch inhibitor LY411575 from 3dpf to 5dpf increased expression atoh1a and s100t. More lin28a …
(A) RNA-Seq analysis using neomycin-treated neuromast cells revealed that lin28a was highly induced at 1 hr post neo while lin28b expression wa s not changed. (B) lin28a was induced at 1 hr post …
(A) Wnt inhibition with hs:dkk1 has no effect on lin28a induction post neo treatment. (B) Expression levels of lin28a, yap, taz and Hippo pathway genes, such as lats1 and mob1, were detected by …
(A) The number of SCs and total cells were counted at 48 hr post LY+neo and were significantly decreased in lin28a mutant compared with sibling. (B–E) The ET4;ET20 larvae were incorporated with EdU …
(A) Diagram shows four exons of lin28a and the position of CIRPSR that was used for creating lin28a mutant. (B–C) Deletion of five nucleotides in the lin28a mutant allele damages the restriction …
We compared numbers of ET4+ HCs and sox2+ progenitors in 5dpf sibling and lin28a-/- and found that they were not changed in lin28-/- in homeostasis (A), LY (B) and LY+neo (C). Scale bar equals 10 μm.
(A–D) ET4;ET20;hs:lin28a larvae were incorporated with BrdU for 24 hr following heat-shock and/or neomycin treatment. (A, B) Overexpression of lin28a increased number of proliferative SCs (SC+) in …
The ET4;ET20;hs:lin28a larvae were heat-shocked at 3dpf or 5dpf and collected after 24 hr for HC and MC counting. Results showed that numbers of HCs and MCs were not significantly changed by …
(A–B) Larvae were stained with sox2 antibody and atoh1a RNA probe at 6 hr post neo or LY+neo treatment. The number of atoh1a+sox2+ cells was significantly increased in LY+neo group. (C–D) The atoh1a:…
(A) The Neo-treated atoh1a:TdTomato;brn3c:GFP larvae was imaged for time lapse. Results showed that one Tomato+ cell turned into two HCs with membrane-bound GFP post neo (blue dots). (B) The …
(A) We created hs:let7 transgenic line and found that it recapitulates the phenotype of lin28a-/- by decreasing proliferative SCs post LY+neo. (B) The induction of EdU+ proliferative cells was …
In situ results show that expression of her4 and dkk2, Notch pathway genes, and fgf3, a Fgf pathway gene, were not affected in hs:lin28a post neo.
(A) It’s known that sox2+ progenitors that are preserved post neo-induced HC injury divide and differentiate to regenerate HCs. To simulate the situation in mammalian inner ear where the progenitors …
(A)ET4;ET20 Larvae were treated with neo and immediately collected for sox2 immunostaining. The white arrowheads pointed out SCs and MCs that were sox2 negative. (B) Total number of SCs or MCs and …
(A) Larvae were treated with LY, neo or LY+neo and collected immediately after neo treatment for sox2 immunostaining. Sox2+ cell numbers were counted, and the results showed that very few sox2+ …
Results showed the intensive cell divisions (CDs) during severe-injury-induced regeneration. Scale bar equals 10 μm.
Result showed that one Tomato+ cell divided and turned into two GFP+hair cells post neo. Scale bar equals 10 μm.
One Tomato+ cell (blue dot) divided and turned into two HCs that are GFP negative in the center. The other two Tomato+ cells (white dots) divided and converted into four sox2+ progenitors. Scale bar …
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Genetic reagent (Danio rerio) | Et(krt4:EGFP)sqet20ET | Parinov et al., 2004 | sqET20; RRID:ZFIN_ZDB-ALT-070628-20 | |
Genetic reagent (Danio rerio) | Et(krt4:EGFP)sqet4ET | Parinov et al., 2004 | sgET4; RRID:ZFIN_ZDB-GENO-110323-1 | |
Genetic reagent (Danio rerio) | Tg(atoh1a: TdTomato)nns8 | Wada et al., 2010 | nns8; RRID:ZFIN_ZDB-GENO-120530-1 | |
Genetic reagent (Danio rerio) | sox2-2a-sfGFPstl84 | Shin et al., 2014 | stl84; RRID:ZFIN_ZDB-GENO-150721-11 | |
Genetic reagent (Danio rerio) | Tg(brn3c:GAP43-GFP) s356t | Xiao et al., 2005 | S356t; RRID:ZFIN_ZDB-GENO-200218-3 | |
Genetic reagent (Danio rerio) | Tg(hsp70l:dkk1-GFP)w32 | Stoick-Cooper et al. (2007) | W32; RRID:ZFIN_ZDB-ALT-070403-1 | |
Genetic reagent (Danio rerio) | Tg(hsp70l:myc-notch1a;cryaa:Cerulean)fb12 | Zhao et al. (2014) | fb12; RRID:ZFIN_ZDB-ALT-140522-5 | |
Genetic reagent (Danio rerio) | Tg(hsp70:atoh1a)x20 | Millimaki et al. (2010) | X20; RRID:ZFIN_ZDB-GENO-110315-10 | |
Genetic reagent (Danio rerio) | yapmw48 | Miesfeld et al., 2015 | Ms48; RRID:ZFIN_ZDB-ALT-160122-5 | |
Genetic reagent (Danio rerio) | Tg(hsp70:lin28a-P2Amcherry;cmlc:GFP)psi30 | this paper | Details in Fish strain information | |
Genetic reagent (Danio rerio) | Tg(hsp70:let7-P2AGFP;cryaa:Venus) | this paper | Details in Fish strain information | |
Genetic reagent (Danio rerio) | lin28apsi37 | this paper | Details in Fish strain information | |
Antibody | anti-sox2 (Rabbit, polyclonal) | Abcam | Cat# Ab97959; RRID:AB_2341193 | IF(1:200) |
Antibody | anti-yap (Rabbit, polyclonal) | CST | Cat# 4912, RRID:AB_2218911 | IF(1:200) |
Antibody | anti-taz (Rabbit, polyclonal) | Abcam | Cat# Ab84927; RRID:AB_1925489 | IF (1:200), WB (1:500) |
Antibody | anti-GFP (Mouse, monoclonal) | Invitrogen | Cat# A11120; RRID:AB_221568 | IF(1:500) |
Antibody | Anti-yap (Mouse, monoclonal) | Santa Cruz | Cat# sc-271134; RRID:AB_10612397 | WB (1:1000) |
Antibody | Anti-lin28a (Rabbit, polyclonal) | CST | Cat# 3978; RRID:AB_2297060 | WB (1:500) |
Antibody | Anti-lats (Rabbit, monoclonal) | CST | Cat# 3477; RRID:AB_2133513 | WB (1:500) |
Antibody | Anti-p-mob1 (Rabbit, monoclonal) | CST | Cat# 8699; RRID:AB_11139998 | WB (1:500) |
Antibody | Anti-β-actin (Mouse, monoclonal) | Sigma | Cat# A1978; RRID:AB_476692 | WB (1:2000) |
Antibody | Anti-digoxingenin POD (sheep, polyclonal) | Roche | 11207733910; RRID:AB_514500 | 1:2000 |
Antibody | Anti-fluorescein POD(sheep, polyclonal) | Roche | 11426346910; RRID:AB_840257 | 1:2000 |
Chemical compound, drug | EdU | Carbosynth | NE08701 | 3.3 mM |
Chemical compound, drug | LY411575 | Santa Cruz | sc-364529 | 2 μM |
Chemical compound, drug | Neomycin sulfate | Sigma | N6386 | 300 μM |
Chemical compound, drug | Alexa Fluor-594 Azide | Thermo Fisher Scientific | N6386 | |
Chemical compound, drug | Verteporfin | Selleckchem | S1786 | 5 μM |
Chemical compound, drug | Copper sulfate | Sigma | 451657 | 50 μM |
Chemical compound, drug | cisplatin | Sigma | 33342 | 500 μM |
Commercial assay or kit | TSA-Cyanine 3 Reagent | PerkinElmer | SAT704A001EA | |
Commercial assay or kit | TSA-FITC Reagent | PerkinElmer | SAT704A001EA | |
Commercial assay or kit | dynabeads | Invitrogen | 10015D |